PerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration Study

Phase 1Positive

AI Analysis

Summary

PerZeption Inc. has been awarded a Phase 1 Small Business Innovation Research (SBIR) grant from the National Eye Institute for a study assessing photostress recovery in age-related macular degeneration.

Clinical Trial Data

Phase

Phase 1

Outcome Details

Phase I SBIR grant awarded

Importance:4/10

Sentiment:

0.60

SBIR grantPhase 1age-related macular degenerationNational Eye Institutesmall business innovation

Related Companies

$NHPAP

Read the original article

Published by PR Newswire Biotech on September 12, 2026 1:26 AM

Read Original